Literature DB >> 26670021

[Guideline-oriented treatment of alcohol-related disorders].

K Mann1, E Hoch2, A Batra3, U Bonnet4, A Günthner5, G Reymann6, M Soyka7, N Wodarz8, M Schäfer9.   

Abstract

Alcohol use disorders (e.g. abuse and dependence) account for a plethora of consequences for affected individuals and for a substantial proportion of the overall burden of disease for the community. To date, existing treatment options are either poorly known by doctors or they are not fully applied and only approximately 15% of potential patients are treated with a mean latent period of 10 years between early symptoms and the first intervention. So-called S3 treatment guidelines were recently developed to close this gap. Representatives of more than 50 learned societies, families and patients were involved. A systematic literature search from 2005 to 2012 was performed and more than 120 recommendations were made. Financing came exclusively from those societies and the academic and treatment institutes involved.This article summarizes the recommendations pertinent for psychiatrists and include early detection and intervention, acute withdrawal and long-term psychotherapy and pharmacotherapy. Classical and new treatment goals are discussed. If the new guidelines were properly applied an increase in patients receiving treatment to 30-40% could be expected, which would improve the quality of lives of affected persons and their families and in Germany would save several thousand lives per year.

Entities:  

Keywords:  Alcohol-related disorders; Evidence based medicine; Treatment guidelines; Treatment prevalence; Withdrawal treatment

Mesh:

Year:  2016        PMID: 26670021     DOI: 10.1007/s00115-015-0022-8

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  55 in total

1.  EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy.

Authors:  R Galvin; G Bråthen; A Ivashynka; M Hillbom; R Tanasescu; M A Leone
Journal:  Eur J Neurol       Date:  2010-12       Impact factor: 6.089

Review 2.  WITHDRAWN: Case management for persons with substance use disorders.

Authors:  Morten Hesse; Wouter Vanderplasschen; Richard Rapp; Eric Broekaert; Mats Fridell
Journal:  Cochrane Database Syst Rev       Date:  2014-04-15

3.  The use of propranolol as a method to manage acute alcohol detoxification.

Authors:  G A Gross
Journal:  J Am Osteopath Assoc       Date:  1982-11

4.  Moderators of effects of motivational enhancements to cognitive behavioral therapy.

Authors:  Andrew Rosenblum; Jeffrey Foote; Charles Cleland; Stephen Magura; Daneyal Mahmood; Nicole Kosanke
Journal:  Am J Drug Alcohol Abuse       Date:  2005       Impact factor: 3.829

Review 5.  Benzodiazepines for alcohol withdrawal.

Authors:  Laura Amato; Silvia Minozzi; Simona Vecchi; Marina Davoli
Journal:  Cochrane Database Syst Rev       Date:  2010-03-17

6.  Efficacy of a combination of flumazenil and gabapentin in the treatment of alcohol dependence: relationship to alcohol withdrawal symptoms.

Authors:  Raymond F Anton; Hugh Myrick; Alicia M Baros; Patricia K Latham; Patrick K Randall; Tara M Wright; Scott H Stewart; Randy Waid; Robert Malcolm
Journal:  J Clin Psychopharmacol       Date:  2009-08       Impact factor: 3.153

7.  A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal.

Authors:  Hugh Myrick; Robert Malcolm; Patrick K Randall; Elizabeth Boyle; Raymond F Anton; Howard C Becker; Carrie L Randall
Journal:  Alcohol Clin Exp Res       Date:  2009-05-26       Impact factor: 3.455

Review 8.  [Anticonvulsants in the treatment of alcoholism].

Authors:  U Bonnet; M Schäfer; C Richter; J Milkereit; J Wiltfang; N Scherbaum; B Lieb
Journal:  Fortschr Neurol Psychiatr       Date:  2009-04-03       Impact factor: 0.752

9.  Is clonidine useful in the treatment of alcohol withdrawal?

Authors:  B J Robinson; G M Robinson; T J Maling; R H Johnson
Journal:  Alcohol Clin Exp Res       Date:  1989-02       Impact factor: 3.455

10.  The histories of withdrawal convulsions and delirium tremens in 1648 alcohol dependent subjects.

Authors:  M A Schuckit; J E Tipp; T Reich; V M Hesselbrock; K K Bucholz
Journal:  Addiction       Date:  1995-10       Impact factor: 6.526

View more
  6 in total

Review 1.  [Standards for treatment in forensic committment according to § 63 and § 64 of the German criminal code : Interdisciplinary task force of the DGPPN].

Authors:  J L Müller; N Saimeh; P Briken; S Eucker; K Hoffmann; M Koller; T Wolf; M Dudeck; C Hartl; A-K Jakovljevic; V Klein; G Knecht; R Müller-Isberner; J Muysers; K Schiltz; D Seifert; A Simon; H Steinböck; W Stuckmann; W Weissbeck; C Wiesemann; R Zeidler
Journal:  Nervenarzt       Date:  2017-08       Impact factor: 1.214

2.  [Pharmacological prophylactic treatment for relapse of alcohol dependence : Results of current meta-analyses].

Authors:  J Mutschler; M Soyka
Journal:  Nervenarzt       Date:  2017-03       Impact factor: 1.214

3.  Factors Associated with Length of Stay in a Swiss Mental Hospital.

Authors:  Benedikt Habermeyer; Hristijana De Gennaro; Rene Channa Frizi; Patrik Roser; Niklaus Stulz
Journal:  Psychiatr Q       Date:  2018-09

Review 4.  A Roadmap for Integrating Neuroscience Into Addiction Treatment: A Consensus of the Neuroscience Interest Group of the International Society of Addiction Medicine.

Authors:  Antonio Verdejo-Garcia; Valentina Lorenzetti; Victoria Manning; Hugh Piercy; Raimondo Bruno; Rob Hester; David Pennington; Serenella Tolomeo; Shalini Arunogiri; Marsha E Bates; Henrietta Bowden-Jones; Salvatore Campanella; Stacey B Daughters; Christos Kouimtsidis; Dan I Lubman; Dieter J Meyerhoff; Annaketurah Ralph; Tara Rezapour; Hosna Tavakoli; Mehran Zare-Bidoky; Anna Zilverstand; Douglas Steele; Scott J Moeller; Martin Paulus; Alex Baldacchino; Hamed Ekhtiari
Journal:  Front Psychiatry       Date:  2019-12-23       Impact factor: 4.157

5.  Protocol for the methamphetamine approach-avoidance training (MAAT) trial, a randomised controlled trial of personalised approach bias modification for methamphetamine use disorder.

Authors:  Joshua B B Garfield; Hugh Piercy; Shalini Arunogiri; Dan I Lubman; Samuel C Campbell; Paul G Sanfilippo; Jeff Gavin; Malcolm Hopwood; Eli Kotler; Suzanne George; Goke Okedara; Lara R Piccoli; Victoria Manning
Journal:  Trials       Date:  2021-01-06       Impact factor: 2.279

6.  A Web-Based Cognitive Bias Modification Intervention (Re-train Your Brain) for Emerging Adults With Co-occurring Social Anxiety and Hazardous Alcohol Use: Protocol for a Multiarm Randomized Controlled Pilot Trial.

Authors:  Katrina Prior; Elske Salemink; Reinout W Wiers; Bethany A Teachman; Monique Piggott; Nicola C Newton; Maree Teesson; Andrew J Baillie; Victoria Manning; Lauren F McLellan; Alison Mahoney; Lexine A Stapinski
Journal:  JMIR Res Protoc       Date:  2021-07-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.